Catalyst Wire Dossier Catalyst Wire Dossier

SUMATRIPTAN AND NAPROXEN SODIUM

Sumatriptan and Naproxen Sodium · NorthStar RxLLC
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for SUMATRIPTAN AND NAPROXEN SODIUM, covering 2018-02-15 to 2025-11-10. Get the full timeline:

Most recent: FDA Approved: SUMATRIPTAN AND NAPROXEN SODIUM — Supplemental Application (NorthStar RxLLC)

See pricing